GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Oscar Health
Who owns Oscar Health today?
The company shifted from VC darling to profitable insurer after Mark Bertolini's 2023–24 leadership, changing investor confidence and governance. Ownership now blends founding insiders, early backers, and large institutional holders.
By 2025 Oscar serves over 1.6 million members and shows stabilized market cap; voting control remains concentrated among early architects and major institutional investors. Explore product analysis: Oscar Health Porter's Five Forces Analysis
Who Founded Oscar Health?
Founders and early ownership of Oscar Health centered on Joshua Kushner, Mario Schlosser, and Kevin Nazemi, who launched a digital-first insurer with venture backing; initial equity was concentrated among the founders and Thrive Capital, which led seed and Series A funding.
Founding team
Joshua Kushner provided strategic and financial backing via Thrive Capital; Mario Schlosser led product and operations as CEO; Kevin Nazemi shaped early product vision before exiting active duties.
Early investor lead
Thrive Capital led initial rounds and held an outsized influence in early ownership and governance through concentrated equity and board representation.
Prestigious backers
Notable early investors included Founders Fund, Khosla Ventures, and General Catalyst, each acquiring material stakes during 2013–2018 scale-up rounds.
Equity structure
Standard founder vesting applied, and governance included super-voting shares to protect founding control amid heavy capital raises.
Capital raised
Between 2013 and 2018 Oscar raised multiple private rounds totaling over $1.5 billion in growth capital prior to its 2021 IPO, concentrating ownership among venture backers and insiders.
Governance impact
Super-voting provisions and board seats ensured founders and key investors retained decision control despite dilution from successive financings.
Regulatory filings and the 2021 IPO later disclosed more detailed ownership: Thrive Capital remained a principal holder with continued influence, while public shareholders and prior venture investors became larger collective stakeholders.
Key facts — founders and ownership
Founders, lead investor roles, and governance features that shaped early ownership.
- Founders: Joshua Kushner, Mario Schlosser, Kevin Nazemi
- Lead early investor: Thrive Capital (strategic and financial lead)
- Other early investors: Founders Fund, Khosla Ventures, General Catalyst
- Governance: founder vesting plus super-voting shares to protect control
For additional context on market positioning and rivals, see Competitors Landscape of Oscar Health.
Complete Oscar Health Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
How Has Oscar Health’s Ownership Changed Over Time?
Key events shaping Oscar Health ownership include the March 3, 2021 IPO that raised about $1.4 billion at an approximate $7 billion valuation, the 2023 CEO transition to Mark Bertolini with equity-linked compensation, and a steady shift from VC/private equity holders toward large institutional investors and strategic partners through 2025.
| Stakeholder | Approx. Ownership (2025) | Notes |
|---|---|---|
| Thrive Capital | ~15% | Largest single investor from pre-IPO rounds; active board representation |
| Alphabet Inc. (various arms) | ~12% | Strategic technology partner; underscores Oscar Health's tech-focused model |
| FMR LLC (Fidelity) | ~10% | Major institutional holder across active funds |
| Vanguard + BlackRock | ~14% (combined) | Passive index and mutual fund holdings reflecting broad investor exposure |
| Insiders (Joshua Kushner, Mario Schlosser, others) | Significant (combined single-digit to low double-digit via vehicles) | Founders and executives retain material voting and economic interest |
| New CEO — Mark Bertolini | Equity incentives tied to long-term performance | Introduced in 2023 to align management with margin expansion goals |
The post-IPO ownership evolution shifted Oscar Health stock ownership from venture capital concentration toward institutional asset managers and strategic tech investors, influencing corporate governance and strategic priorities including margin expansion and B2B platform growth; see the company’s SEC filings for precise percentage changes.
Major ownership takeaways
Oscar Health ownership now reflects a mix of strategic, institutional, and insider stakes that guide board and management decisions.
- IPO on March 3, 2021 raised $1.4 billion at ~$7 billion valuation
- Thrive Capital remains the largest single investor with ~15%
- Alphabet holds ~12%, highlighting technology partnership
- Fidelity, Vanguard, and BlackRock together account for a substantial institutional block
For deeper context on Oscar Health’s strategy and how ownership informs product and market moves, see Marketing Strategy of Oscar Health.
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
Who Sits on Oscar Health’s Board?
As of early 2026, Oscar Health's board combines healthcare veterans and tech-focused founders, led by Chairman and CEO Mark Bertolini with Joshua Kushner as Vice Chairman; the board mixes executive and independent directors guiding strategic growth and governance.
| Director | Role | Background |
|---|---|---|
| Mark Bertolini | Chairman & CEO | Healthcare executive, insurer turnaround experience |
| Joshua Kushner | Vice Chairman | Founder-investor, major shareholder (Class B) |
| Mario Schlosser | Director | Technology and operations leader |
| Chelsea Clinton | Independent Director | Public policy and philanthropy |
Oscar Health employs a dual-class share structure: Class A common stock carries one vote per share, while Class B carries 20 votes per share, concentrating control with founders and early investors and separating economic ownership from voting power.
Board Control & Voting Power
The Class B shares, held mainly by Joshua Kushner and entities affiliated with Thrive Capital, provide over 75% of voting power, classifying Oscar Health as a NYSE 'controlled company'.
- Dual-class structure creates voting-economic divergence
- Founders and early investors hold decisive voting blocks
- Board stability maintained; no successful proxy battles through early 2026
- Enables long-term strategic moves like the 2024 ICHRA expansion
Oscar Health Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What Recent Changes Have Shaped Oscar Health’s Ownership Landscape?
From 2023 through 2025 Oscar Health's ownership shifted toward greater institutional stability, with rising positions from healthcare-focused hedge funds and insurers as the company moved from a speculative IPO profile to sustained profitability and operational maturity.
| Year | Ownership Trend | Notable Impact |
|---|---|---|
| 2023 | Post-IPO volatility declines; institutional accumulation begins | Early lock-ups expire; founders retain concentrated voting power |
| 2024 | Full-year positive GAAP net income reported; buy-side interest increases | First full-year GAAP profit triggered analyst reclassification toward healthcare value |
| 2025 | Capital allocation prioritizes tech reinvestment over buybacks; shareholder support from major backers | Alphabet and major strategic investors back reinvestment strategy; ICHRA leadership cited as growth driver |
Institutional diversification included funds specializing in value-based care and insurtech, while concentrated founder voting power continued to shape strategic possibilities for mergers or privatization.
Ownership shift to institutions
Healthcare-focused hedge funds and institutional investors increased stakes after 2024 profitability, improving stability in Oscar Health stock ownership.
Founders' voting control
Founders retained concentrated voting power, meaning any major corporate action requires their consent despite broader institutional holding.
Capital allocation priorities
In 2025 the company emphasized reinvesting profits into its technology stack rather than aggressive share buybacks, supported by significant investors.
Growth catalyst: ICHRA
Analysts cite Oscar's position in the ICHRA market as a primary driver for future ownership interest and institutional inflows.
Further reading on the company’s revenue model and investor appeal: Revenue Streams & Business Model of Oscar Health
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Brief History of Oscar Health Company?
- What is Competitive Landscape of Oscar Health Company?
- What is Growth Strategy and Future Prospects of Oscar Health Company?
- How Does Oscar Health Company Work?
- What is Sales and Marketing Strategy of Oscar Health Company?
- What are Mission Vision & Core Values of Oscar Health Company?
- What is Customer Demographics and Target Market of Oscar Health Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.